首页|坤泰胶囊联合雌二醇屈螺酮片治疗围绝经期综合征患者的效果

坤泰胶囊联合雌二醇屈螺酮片治疗围绝经期综合征患者的效果

扫码查看
目的:观察坤泰胶囊联合雌二醇屈螺酮片治疗围绝经期综合征患者的效果.方法:选取 2023 年 1-12 月该院收治的120例围绝经期综合征患者进行前瞻性研究,按照随机数字表法将其分为对照组和观察组各60例.对照组予以雌二醇屈螺酮片治疗,观察组在对照组基础上联合坤泰胶囊治疗.比较两组临床疗效,治疗前后中医证候积分、性激素[抗米勒管激素(AMH)、雌二醇(E2)、黄体生成素(LH)]水平、T细胞亚群指标(CD3+、CD4+、CD8+、CD4+/CD8+)水平,以及不良反应发生率.结果:观察组治疗总有效率为91.67%(55/60),高于对照组的78.33%(47/60),差异有统计学意义(P<0.05);治疗后,观察组主症、次症等中医证候积分均低于对照组,差异有统计学意义(P<0.05);治疗后,观察组E2、AMH水平高于对照组,LH水平低于对照组,差异均有统计学意义(P<0.05);治疗后,观察组CD3+、CD4+、CD4+/CD8+水平高于对照组,CD8+水平低于对照组,差异均有统计学意义(P<0.05);两组不良反应发生率比较,差异无统计学意义(P>0.05).结论:坤泰胶囊联合雌二醇屈螺酮片治疗围绝经期综合征患者可提高治疗总有效率,降低中医证候积分,改善性激素、T细胞亚群指标水平,效果优于单纯雌二醇屈螺酮片治疗.
Effects of Kuntai capsules combined with Estradiol and Drospirenone tablets in treatment of perimenopausal syndrome
Objective:To observe effects of Kuntai capsules combined with Estradiol and Drospirenone tablets in treatment of perimenopausal syndrome.Methods:A prospective study was conducted on 120 patients with perimenopausal syndrome admitted to this hospital from January to December 2023.According to the random number table method,they were divided into control group and observation group,60 cases in each group.The control group was treated with Estradiol and Drospirenone tablets,while the observation group was treated with Kuntai capsules on the basis of that of the control group.The clinical efficacy,the TCM syndrome score,the sex hormones[anti-Millerian hormone(AMH),estradiol(E2),luteinizing hormone(LH)]levels and the T cell subsets(CD3+,CD4+,CD8+,CD4+/CD8+)levels before and after the treatment,and the incidence of adverse reactions were compared between the two groups.Results:The total effective rate of the observation group was 91.67%(55/60),which was higher than 78.33%(47/60)of the control group,and the difference was statistically significant(P<0.05).After the treatment,the scores of TCM syndromes such as main symptoms and secondary symptoms in the observation group were lower than those in the control group,and the differences were statistically significant(P<0.05).After the treatment,the levels of E2 and AMH in the observation group were higher than those in the control group,the level of LH was lower than that in the control group,and the differences were statistically significant(P<0.05).After the treatment,the levels of CD3+,CD4+and CD4+/CD8+in the observation group were higher than those in the control group,the level of CD8+was lower than that in the control group,and the differences were statistically significant(P<0.05).However,there was no significant difference in the incidence of adverse reactions between the two groups(P>0.05).Conclusions:Kuntai capsules combined with Estradiol and Drospirenone tablets in the treatment of perimenopausal syndrome can improve the total effective rate of treatment,reduce the TCM syndrome scores,and improve the levels of sex hormones and T cell subsets.Moreover,it is superior to single Estradiol and Drospirenone tablets treatment.

Perimenopausal syndromeEstradiol and Drospirenone tabletsKuntai capsulesTCM syndrome scoreSex hormoneT cell subsetAdverse reaction

翟文杰

展开 >

淄博市博山区计划生育服务中心区妇幼保健院妇产科,山东 淄博 255200

围绝经期综合征 雌二醇屈螺酮片 坤泰胶囊 中医证候积分 性激素 T细胞亚群 不良反应

2024

中国民康医学
中国社会工作协会

中国民康医学

影响因子:0.649
ISSN:1672-0369
年,卷(期):2024.36(14)
  • 12